Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | MSCI ACWI IMI Innovation Select Screened 200 |
| Investment focus | Equity, World, Social/Environmental |
| Fund size | EUR 6 m |
| Total expense ratio | 0.30% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Investment approach | Long-only |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 15.63% |
| Inception/ Listing Date | 12 July 2022 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | Xtrackers |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | State Street Custodial Services (Ireland) Limited |
| Investment Advisor | DWS Investments UK Limited |
| Custodian Bank | State Street Custodial Services (Ireland) Limited, Dublin 2 |
| Revision Company | Pricewaterhouse Coopers |
| Fiscal Year End | 31 December |
| Swiss representative | DWS CH AG |
| Swiss paying agent | Deutsche Bank (Suisse) SA |
| Germany | 30% tax rebate |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Italy | 26.0% |
| Indextype | - |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
| Apple | 5.01% |
| Vertex Pharmaceuticals | 4.97% |
| Mastercard, Inc. | 4.96% |
| Visa, Inc. | 4.90% |
| Roche Holding AG | 4.56% |
| Microsoft Corp | 4.15% |
| NVIDIA Corp. | 3.93% |
| Taiwan Semiconductor Manufacturing Co., Ltd. | 3.54% |
| AMD | 3.18% |
| Amazon.com, Inc. | 3.16% |
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
| | 0.00 € | 0.00 € | View offer** | |
| | 0.00 € | 0.00 € | View offer* | |
| | 0.00 € | 0.00 € | View offer* | |
| | 0.00 € | 0.00 € | View offer* | |
| | 0.00 € | 0.00 € | View offer* |
| Broker | Rating | Order fee | ETF savings plans | |
|---|---|---|---|---|
| | 0.00 € | 3554 | View offer** | |
| | 0.00 € | 2605 | View offer* | |
| | 0.95 € | 2532 | View offer* | |
| | 1.00 € | 2625 | View offer* | |
| | 0.00 € | 1868 | View offer* |
| YTD | +14.75% |
| 1 month | +3.79% |
| 3 months | +8.38% |
| 6 months | +20.38% |
| 1 year | +18.45% |
| 3 years | +52.28% |
| 5 years | - |
| Since inception (MAX) | +70.26% |
| 2025 | +1.39% |
| 2024 | +29.60% |
| 2023 | +27.60% |
| 2022 | - |
| Volatility 1 year | 15.63% |
| Volatility 3 years | 17.09% |
| Volatility 5 years | - |
| Return per risk 1 year | 1.18 |
| Return per risk 3 years | 0.88 |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -15.42% |
| Maximum drawdown 3 years | -24.16% |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -24.16% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | XNNV | - - | - - | - |
| Borsa Italiana | EUR | XNNV | XNNV IM XNNVEUIV | XNNV.MI XNNVEURINAV=SOLA | |
| London Stock Exchange | USD | XNNV | XNNV LN XNNVUSIV | XNNV.L XNNVUSDINAV=SOLA | |
| XETRA | EUR | XNNV | XNNV GY | XNNV.DE |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares Healthcare Innovation UCITS ETF | 1,202 | 0.40% p.a. | Accumulating | Sampling |
| WisdomTree Megatrends UCITS ETF USD | 57 | 0.50% p.a. | Accumulating | Full replication |
| VanEck Genomics and Healthcare Innovators UCITS ETF A | 16 | 0.35% p.a. | Accumulating | Full replication |
| Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C | 10 | 0.30% p.a. | Accumulating | Full replication |
| WisdomTree Tech Megatrends UCITS ETF USD Acc | 3 | 0.50% p.a. | Accumulating | Sampling |